Viewing nowGlycita Tablet 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202102395 · Approved 2021.03.17 · Insurance code 657308540
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to control blood sugar in patients with type 2 diabetes. Initially, it can be administered alone in conjunction with dietary and exercise therapy. If blood sugar control is insufficient, it can be used in combination with metformin. Additionally, if controlling blood sugar remains difficult despite using other diabetes medications such as sulfonylureas, thiazolidinediones, and insulin, this medication may be added to the treatment regimen. This helps improve blood sugar control.
This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken without regard to meals. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.
This medication may cause severe hypersensitivity reactions after administration, so if allergy symptoms are suspected, use should be discontinued immediately. Symptoms of serious pancreatic issues such as acute pancreatitis may appear, so caution is advised for symptoms such as abdominal pain or vomiting. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor should it be administered to patients allergic to this medication or any of its ingredients. Dose adjustment is necessary for patients with reduced kidney function, so regular kidney function tests should be conducted. Reported side effects in clinical trials include upper respiratory infections, headaches, nasopharyngitis, dyspepsia, diarrhea, and hypoglycemic symptoms may also occur. When taken with other blood sugar lowering agents, especially insulin or sulfonylureas, there is an increased risk of hypoglycemia, so caution is required. Severe adverse reactions such as serious joint pain or skin blisters may occur, and if these symptoms appear, immediate consultation with healthcare professionals is necessary. It is preferable for women who are pregnant or breastfeeding not to take this medication, and the safety of this medication for children and adolescents under 18 years of age has not been established. In the case of overdose, general treatment should be administered, and if necessary, hemodialysis can be performed to remove the drug. This medication does not pose safety concerns regarding cardiovascular effects, and it can be used relatively safely in elderly individuals, although kidney function status should be monitored regularly.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, peripheral edema, constipation, vomiting, arthralgia associated with severity and disability, vesicular pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritis, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, rash, urticaria, cutaneous vasculitis, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and maintained at a temperature between 1 to 30 degrees Celsius for safety. Storing it this way will help maintain the medication's effectiveness.
Light apricot colored, biconvex, round, film-coated tablets
28 tablets/box [14 tablets/PTPX2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.